4.6 (400) · $ 10.50 · In stock
Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.
Frontiers Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
Combatting Cancer through Science-based, Patient-centered Policies
AstraZeneca on X: Throughout Cancer Immunotherapy Month and beyond, our team of scientists never stop pushing the boundaries of precision medicine to bring the benefits of Immuno-Oncology to earlier stages of disease
Unearthing the Potential of the Next Frontier
Cancer Research Impact New Immunotherapy Developed
Advancing Cancer Science and Medicine
Turning Science into Lifesaving Care
Diseases, Free Full-Text
American Association for Cancer Research (AACR)